Zeke Capital Advisors, LLC Blueprint Medicines Corp Transaction History

Zeke Capital Advisors, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$54.1 - $110.08 $71,574 - $145,635	1,323 Added 35.76%	5,023 $321,000
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $13,383 - $16,470	-142 Reduced 3.7%	3,700 $396,000
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $40,148 - $48,985	485 Added 14.45%	3,842 $338,000
Q1 2021 Apr 21, 2021	BUY	$90.71 - $108.28 $120,644 - $144,012	1,330 Added 65.61%	3,357 $326,000
Q4 2020 Feb 10, 2021	SELL	$92.08 - $124.48 $22,559 - $30,497	-245 Reduced 10.78%	2,027 $227,000
Q3 2020 Nov 09, 2020	BUY	$66.45 - $92.7 $150,974 - $210,614	2,272 New	2,272 $211,000
Q1 2020 Apr 24, 2020	SELL	$48.11 - $82.22 $458,295 - $783,227	-9,526 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$66.73 - $82.59 $152,678 - $188,965	2,288 Added 31.61%	9,526 $763,000
Q3 2019 Oct 18, 2019	BUY	$72.9 - $101.41 $139,603 - $194,200	1,915 Added 35.98%	7,238 $532,000
Q2 2019 Jul 24, 2019	BUY	$73.54 - $97.8 $103,470 - $137,604	1,407 Added 35.93%	5,323 $502,000
Q1 2019 Apr 29, 2019	SELL	$48.7 - $86.6 $389,502 - $692,626	-7,998 Reduced 67.13%	3,916 $313,000
Q4 2018 Feb 11, 2019	BUY	$45.57 - $74.26 $164,689 - $268,375	3,614 Added 43.54%	11,914 $642,000
Q3 2018 Nov 08, 2018	BUY	$58.91 - $78.32 $488,953 - $650,056	8,300 New	8,300 $648,000
Q2 2018 Jul 24, 2018	SELL	$60.96 - $101.18 $137,342 - $227,958	-2,253 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$73.28 - $102.95 $165,099 - $231,946	2,253 New	2,253 $207,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Zeke Capital Advisors, LLC with notifications on news.